Literature DB >> 33194859

Masquerading Hypervascular Exophytic Liver Nodule.

Kevin Kim-Jun Teh1, Albert Su-Chong Low2,3, Jason Pik-Eu Chang1,3, Chee-Kiat Tan1,3.   

Abstract

Patients with liver cirrhosis are at increased risk of developing hepatocellular carcinoma (HCC) and are placed on routine surveillance for HCC. Diagnosis algorithms are in place to guide clinicians in the evaluation of liver lesions detected during surveillance. Radiological assessments are critical with diagnostic criteria based on identification of typical hallmarks of HCCs on multiphasic computed tomography (CT) and dynamic contrast-enhanced magnetic resonance imaging (MRI). We report a patient with a hypervascular exophytic lesion indeterminate for HCC on CT imaging. While the detection of an exophytic arterially-enhancing lesion in an at-risk patient on CT imaging may prompt clinicians to treat the lesion as HCC without further evaluation, the patient underwent contrast-enhanced MRI with the lesion being eventually diagnosed as an exophytic haemangioma. Thus, no further action was necessary and the patient was continued on routine HCC surveillance. LEARNING POINTS: Radiological surveillance for hepatocellular carcinoma (HCC) is routine in patients at risk of HCC.Diagnosis algorithms that are in place for indeterminate lesions detected during HCC surveillance should be adhered to in order to achieve an accurate diagnosis.Sequential imaging with contrast-enhanced (gadoxetate) MRI should be used to obviate the need for an invasive biopsy when an exophytic lesion indeterminate for HCC is identified during CT imaging in a patient with liver cirrhosis, especially when a hepatic haemangioma remains a differential diagnosis. © EFIM 2020.

Entities:  

Keywords:  Exophytic liver nodule; hepatic haemangioma; hepatocellular carcinoma surveillance

Year:  2020        PMID: 33194859      PMCID: PMC7654990          DOI: 10.12890/2020_001840

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  4 in total

1.  EASL Clinical Practice Guidelines on the management of benign liver tumours.

Authors: 
Journal:  J Hepatol       Date:  2016-04-13       Impact factor: 25.083

Review 2.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2018-04-05       Impact factor: 25.083

3.  Comparison of portal venous and delayed phases of gadolinium-enhanced magnetic resonance imaging study of cirrhotic liver for the detection of contrast washout of hypervascular hepatocellular carcinoma.

Authors:  Lorenzo Cereser; Alessandro Furlan; Daniele Bagatto; Rossano Girometti; Giuseppe Como; Claudio Avellini; Maria Orsaria; Chiara Zuiani; Massimo Bazzocchi
Journal:  J Comput Assist Tomogr       Date:  2010 Sep-Oct       Impact factor: 1.826

4.  Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images.

Authors:  R C Semelka; E D Brown; S M Ascher; R H Patt; A S Bagley; W Li; R R Edelman; J P Shoenut; J J Brown
Journal:  Radiology       Date:  1994-08       Impact factor: 11.105

  4 in total
  1 in total

1.  Diagnosis of Liver Cirrhosis and Liver Fibrosis by Artificial Intelligence Algorithm-Based Multislice Spiral Computed Tomography.

Authors:  Liexiu Wu; Bo Ning; Jianjun Yang; Yanni Chen; Caihong Zhang; Yun Yan
Journal:  Comput Math Methods Med       Date:  2022-03-15       Impact factor: 2.238

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.